Nordic Bioscience is participating in 2022 ASCO
Our team is looking forward to participating at 2022 ASCO, the world's premier oncology research event. This year the meeting's theme: Advancing Equitable Cancer Care Through Innovation. The team will be present in Chicago in person and are excited to meet the greatest scientific minds of the cancer research field.
We are happy to announce that the following two posters will showcase Nordic Bioscience data from our latest research:
Abstract Number for Publication: 4082
Abstract Title: The potential use of blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
Session Title: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Session Date and Time:
Saturday, June 4, 2022, 8:00 AM-11:00 AM CDT
Presenter:
Troels Dreier Christensen, Copenhagen University Hospital
Abstract Number for Publication: 2059
Abstract Title: Indirect assessment of tumor-infiltrating lymphocyte activity in serum for predicting outcome in glioblastoma patients treated with immunotherapy in the recurrent setting.
Session Title: Central Nervous System Tumors
Session Date and Time:
Sunday, June 5, 2022, 8:00 AM-11:00 AM CDT
Presenter:
Nicholas Willumsen / Neel I. Nissen, Nordic Bioscience
We are looking forward to meeting you!
